Educational Videos, Forum Videos
New Treatments including Cabozantinib presented by Dr Chris Lomma
NET Patient Forum Perth 2026 - New Treatments including Cabozantinib presented by Dr Chris Lomma
Resources
Filter by:
Or browse by
popular tag:
Support Groups
NSW & ACT Support Groups
Educational Videos
Nutrition and NETs Webinar – the latest research
Booklets & Guides
Nutrition and Neuroendocrine Tumours
Clinical Trials
ONJCRI Immunotherapy Trial: Nivolumab & Ipilimumab for Rare and Advanced Cancers
This protocol provides an important opportunity to establish whether the combination of nivolumab & ipilimumab has efficacy in these cancers.
Support Groups
Online Support Groups
Educational Videos
Optimal Care Pathway for Neuroendocrine Tumours (NETs)
Fact Sheets
Palliative Care & End of Life Care Resource List
Fact Sheets
Para & Phaeo Factsheet
Wellness
Parenting through Cancer
Clinical Trials
PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET)
PARLuNET is a phase 1 dose-escalation study designed to evaluate the safety and tolerability of talazoparib (PARP Inhibitor) in...
Other Resources
Patient Card – Bathroom
Other Resources
Patient Card – Carcinoid Crisis Medical Alert
Educational Videos, Explainer Videos
Peptide receptor radionuclide therapy (PRRT)
Forum Videos
Perth NET Patient Forum 2023
Clinical Trials
Phase 3 Trial of CAM2029 vs Standard Treatments in GEP-NET Patients
The purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET.
